Last update : 02/03/2012 | Version : 2 | ID : 122
General | |
Identification | |
Detailed name | Survey of the therapeutic management of rheumatoid arthritis in France in 2006 |
Sign or acronym | OPALE |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL 833542 version 11 |
General Aspects | |
Medical area |
Rheumatology |
Health determinants |
Genetic |
Others (details) | rheumatoid arthritis |
Keywords | Rheumatoid arthritis, epidemiology, DMARD, treatments |
Scientific investigator(s) (Contact) | |
Name of the director | Bregman |
Surname | Bruno |
Address | 3, rue J. Monier - 92500 Rueil Malmaison |
Phone | +33 (0)1 58 83 60 00 |
bruno.bregman@bms.com | |
Unit | Bristol-Myers Squibb |
Name of the director | Schmidely |
Surname | Nathalie |
Address | 3, rue J. Monier - 92500 Rueil Malmaison |
Phone | +33 (0)1 58 83 60 00 |
nathalie.schmidely@bms.com | |
Unit | Bristol-Myers Squibb |
Collaborations | |
Funding | |
Funding status |
Private |
Details | Bristol-Myers Squibb |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Bristol-Myers Squibb (BMS) |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Random sampling in clusters |
Database objective | |
Main objective | Describe the therapeutic pratice used by French rhumatologists in patients suffering from rheumatoid arthritis patients, and describe the treatment patterns used, in a general manner and according to the patients' and disease characteristics. |
Inclusion criteria |
Register Part: M/F >=18 years, with a midl to severe rheumatoid arthritis currently treated or not treated with either symptomatic agents or DMARD (disease-modifying anti-rheumatism drug treatment) (biological or non-biological), seen in rheumatology clinic visit. Detailed Study Part: patients eligible for the register part, currently treated or initiating a first DMARD (disease-modifying anti-rheumatism drug treatment) (biological or non-biological) at the time of inclusion in the study |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | Metropolitan France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2006 |
Date of last collection (YYYY or MM/YYYY) | 2006 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 1600 |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Biological data |
Clinical data (detail) |
Direct physical measures |
Biological data (detail) | ESR, CRP, Rheumatoid factor, HLA DR4, Anti CCP |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity |
Procedures | |
Data collection method | Paper or electronic form |
Participant monitoring |
No |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://tinyurl.com/PUBMED-OPALE |
Description | |
Link to the document | http://tinyurl.com/HAL-OPALE |
Description | |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Publications |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05